Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 14 - Issue 4 - April, 2002

News

Teaching Collection
Late-Term Myocardial Infarction After Surgical Ligation of a Giant Coronary Artery Fistula
08/01/2008
Steven L. Goldberg, MD, *Joel Manchester, MD, **Hillel Laks, MD, **Joseph Perloff, MD
Steven L. Goldberg, MD, *Joel Manche...
Large coronary artery fistulae have been associated with complications such as congestive heart failure, myocardial ischemia, endocarditis, rupture and arrhythmias.1 To reduce the risk of complications, large coronary artery fistulae are...
Large coronary artery fistulae have been associated with complications such as congestive heart failure, myocardial ischemia, endocarditis, rupture and arrhythmias.1 To reduce the risk of complications, large coronary artery fistulae are...
Large coronary artery fistulae...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
Management of Dissection and Other <br />
Complications – <br />
<br />
Spontaneous Dissection of Bilateral Internal Mammary Arterial Grafts
08/01/2008
Ahmad Qaddour, MD and Chanwit Roongsritong, MD
Ahmad Qaddour, MD and Chanwit Roongsr...
Arterial graft dissection is a rare complication of cardiac catheterization. Spontaneous dissection has not been previously described. We report a case of a 49-year-old male with quadruple bypass grafts who presented with acute myocardial...
Arterial graft dissection is a rare complication of cardiac catheterization. Spontaneous dissection has not been previously described. We report a case of a 49-year-old male with quadruple bypass grafts who presented with acute myocardial...
Arterial graft dissection is a...
08/01/2008
Journal of Invasive Cardiology
Predictors of Recurrent Restenosis After Coronary Stenting: An Analysis of 197 Patients
08/01/2008
Koichi Kishi, MD, Yoshikazu Hiasa, MD, Naoki Suzuki, MD, Hiroshi Miyamoto, MD, Takefumi Takahashi, MD, Shinobu Hosokawa, MD, Masato Tanimoto, MD, Ryuji Otani, MD
Koichi Kishi, MD, Yoshikazu Hiasa, MD...
In recent years, coronary stent placement has become an established treatment for patients with coronary artery disease.1,2 However, in-stent restenosis has been reported to occur in 20–30% of patients, and the restenosis rate after treatment...
In recent years, coronary stent placement has become an established treatment for patients with coronary artery disease.1,2 However, in-stent restenosis has been reported to occur in 20–30% of patients, and the restenosis rate after treatment...
In recent years, coronary stent...
08/01/2008
Journal of Invasive Cardiology
Safety and Efficacy of Using 0.052-inch Gianturco Coil for Closure of Large (&gt;= 4 mm) Patent Ductus Arteriosus
08/01/2008
Ta-Cheng Huang, MD, Kai-Sheng Hsieh, MD, Cheng-Liang Lee, MD, Chu-Chun Lin, MD
Ta-Cheng Huang, MD, Kai-Sheng Hsieh,...
Transcatheter closure of a small patent ductus arteriosus (PDA) is now an established treatment in many pediatric cardiology centers. As for occlusion of large PDA, interventional cardiologists are still looking for a simple, but safe and...
Transcatheter closure of a small patent ductus arteriosus (PDA) is now an established treatment in many pediatric cardiology centers. As for occlusion of large PDA, interventional cardiologists are still looking for a simple, but safe and...
Transcatheter closure of a small...
08/01/2008
Journal of Invasive Cardiology
Laser Angioplasty and Laser-Induced<br />
Thrombolysis in Revascularization of<br />
Anomalous Coronary Arteries
08/01/2008
Rakesh Shah, MD, Robert E. Martin, MD, On Topaz, MD
Rakesh Shah, MD, Robert E. Martin, M...
Anomalous origin of the coronary arteries occurs in only 0.64–1.2% of patients undergoing coronary angiography.1,2 In symptomatic patients with atherosclerotic coronary disease, precise angiographic recognition of the origin and the anatomic...
Anomalous origin of the coronary arteries occurs in only 0.64–1.2% of patients undergoing coronary angiography.1,2 In symptomatic patients with atherosclerotic coronary disease, precise angiographic recognition of the origin and the anatomic...
Anomalous origin of the coronary...
08/01/2008
Journal of Invasive Cardiology
Myocardial Injury After Apparently Successful Coronary Stenting With or Without Balloon Dilation: Direct Versus Conventional Ste
08/01/2008
Timur Timurkaynak, MD, Murat Ozdemir, MD, Atiye Cengel, MD, Haci Ciftci, MD, Mustafa Cemri, MD, Guliz Erdem, Ridvan Yalcin, MD, Bulent Boyaci, MD, Ovsev Dortlemez, MD, Halis Dortlemez, MD
Timur Timurkaynak, MD, Murat Ozdemir...
Direct stenting (DS) without balloon predilation is a novel approach in the percutaneous treatment of coronary artery lesions. This approach, besides reducing aggression to the vessel wall, may also significantly lower the rate of procedural...
Direct stenting (DS) without balloon predilation is a novel approach in the percutaneous treatment of coronary artery lesions. This approach, besides reducing aggression to the vessel wall, may also significantly lower the rate of procedural...
Direct stenting (DS) without...
08/01/2008
Journal of Invasive Cardiology
Aqueous Oxygen Hyperbaric Reperfusion in a Porcine Model of Myocardial Infarction
08/01/2008
J. Richard Spears, MD, Cassandra Henney, ATC, PhD, Petar Prcevski, DVM, Rui Xu, MD, Li Li, PhD, Giles J. Brereton, PhD, Marcello DiCarli, MD, Ali Spanta, MD, Richard Crilly, PhD, Abdulbaset M. Sulaiman, MD, Samir Hadeed, MD, Steven Lavine, MD, William R. Patterson, PhD, Jeffrey Creech, PhD, Richard Vander Heide, MD, PhD
J. Richard Spears, MD, Cassandra Hen...
Hyperbaric oxygen (HBO) administered during reperfusion has been shown experimentally to reduce tissue injury associated with ischemia/reperfusion of a wide variety of tissues,1–8 including myocardium. Potential mechanisms include inhibition...
Hyperbaric oxygen (HBO) administered during reperfusion has been shown experimentally to reduce tissue injury associated with ischemia/reperfusion of a wide variety of tissues,1–8 including myocardium. Potential mechanisms include inhibition...
Hyperbaric oxygen (HBO)...
08/01/2008
Journal of Invasive Cardiology
Feature
Overcoming Heparin Limitations in High-Risk Percutaneous Coronary Intervention: The Alternative Strategy — Replacing Heparin wit
08/01/2008
Timothy D. Henry, MD
Timothy D. Henry, MD
Adverse outcomes of PCI include myocardial ischemia and necrosis, the need for endovascular or surgical reintervention, and occasionally death.1–3 Routine pharmacologic therapy includes antiplatelet and antithrombotic agents. Heparin has been...
Adverse outcomes of PCI include myocardial ischemia and necrosis, the need for endovascular or surgical reintervention, and occasionally death.1–3 Routine pharmacologic therapy includes antiplatelet and antithrombotic agents. Heparin has been...
Adverse outcomes of PCI include...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Coil Closure of the Large Patent Arterial Duct: Cheap, But How Easy and Effective?
08/01/2008
Ziyad M. Hijazi, MD, MPH
Ziyad M. Hijazi, MD, MPH
Coil occlusion has become an accepted alternative treatment for small to moderate sized patent ductus arteriosus (PDA). Gianturco coils (Cook Cardiology, Inc., Bloomington, Indiana) are small, coiled spring wires with fabric strands woven...
Coil occlusion has become an accepted alternative treatment for small to moderate sized patent ductus arteriosus (PDA). Gianturco coils (Cook Cardiology, Inc., Bloomington, Indiana) are small, coiled spring wires with fabric strands woven...
Coil occlusion has become an...
08/01/2008
Journal of Invasive Cardiology
Commentary
Incremental Progress? The Roles of Direct Stenting and Routine Troponin Measurement After Percutaneous Coronary Intervention
08/01/2008
Stephen G. Ellis, MD
Stephen G. Ellis, MD
In this issue of the Journal, Timurkaynak et al. raises some important, but not easily resolvable, issues that deserve thought by practicing interventional cardiologists. In this small, observational study measuring cardiac enzymes after PCI,...
In this issue of the Journal, Timurkaynak et al. raises some important, but not easily resolvable, issues that deserve thought by practicing interventional cardiologists. In this small, observational study measuring cardiac enzymes after PCI,...
In this issue of the Journal,...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

April 2002 Volume 14 Issue 4

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement